IperionX Limited Overview
IperionX is a pre-scale, US-focused titanium metal and critical-minerals company. It is building a vertically integrated domestic titanium supply chain that runs from mineral sands to finished components. Its core intellectual property is a family of patented powder-metallurgy processes. HAMR™ (Hydrogen Assisted Metallothermic Reduction) de-oxygenates titanium feedstock (scrap or mineral) into low-cost titanium powder. HSPT™ (Hydrogen Sintering and Phase Transformation) and related downstream processes turn that powder into near-net-shape titanium parts such as fasteners. The company says HAMR produces titanium powder at 40–70% lower cost than the incumbent Kroll process. Operations centre on a Titanium Manufacturing Campus in South Boston, Virginia. This campus moved to 24/7 production in the March 2026 quarter and targets an annualised run-rate of about 200 tpa of powder by end-CY2026, scaling to about 1,400 tpa with US Department of Defense (DoD/"Department of War") IBAS funding. Upstream, it owns the Titan Critical Minerals Project in Tennessee, whose DFS shows an after-tax NPV8 of US$813M. Commercially, the company is still at the pre-revenue/early-revenue stage and depends heavily on government funding.
What the company does
IperionX positions itself as an American titanium metal and critical materials company. It uses patented technologies to make high-performance titanium alloys from titanium minerals or scrap titanium, and claims lower energy use, cost and carbon emissions than conventional routes (company description as syndicated via FNN, July 2026). The business has two linked pillars.
-
Titanium metal and products (Virginia). HAMR converts titanium feedstock into titanium powder that the company says meets or exceeds Grade 5 (Ti-6Al-4V) quality parameters [Q4 FY26]. Downstream processes (HSPT™, THRM™ and powder metallurgy pressing) turn the powder into near-net-shape components. The company commissioned a six-axis powder metallurgy press in May 2026 and says it triples existing powder-metallurgy capacity [Q4 FY26]. Spherical powders for additive manufacturing are also in qualification [Q3 FY26].
-
Critical minerals (Tennessee). The 100%-owned Titan Project near Camden, Tennessee is a near-surface, free-dig mineral sands deposit. It is designed to produce ilmenite, rutile, zircon and a Heavy Rare Earth Concentrate (HREC). The DFS supports an initial 14-year mine plan [DFS]. The adjacent Atlas property was acquired on 1 July 2026 for US$3M [Q4 FY26].
Business and revenue model
| Revenue / funding stream | Status (latest disclosure) | Character |
|---|---|---|
| Titanium powder sales (direct) | Production in ramp-up; supports qualification programmes and direct powder requirements [Q4 FY26] | Product |
| Near-net-shape titanium components (fasteners, pump/valve parts, defence parts) | Prototype and qualification orders; US Army GVSC prototype fastener order for the Joint Light Tactical Vehicle (JLTV), July 2026 | Product (engineered) |
| US Government contracts and awards | IBAS US$47.1M (fully obligated); DPA Title III US$12.7M; SBIR Phase III contract vehicle up to US$99M [20-F FY26 summary via Quartr] | Cost-reimbursement funding and contract revenue |
| Mineral concentrates (ilmenite, rutile, zircon, HREC) | Pre-development; DFS complete, project finance needed | Future product |
| Licensing of IP | No licensing revenue disclosed | — |
The company's stated core growth opportunity is finished titanium components rather than powder. It made this point explicitly in its November 2025 response to Spruce Point. Management expects customer revenue to begin and scale in 2H CY2026 as qualification programmes convert to purchase orders [Q3 FY26].
Value chain position
IperionX aims to cover the full chain: mineral sands mining (Titan/Atlas), then primary titanium metal powder (HAMR, which bypasses Kroll sponge and melting), then alloy powder, then near-net-shape and finished components (HSPT/press/AM). Its scrap-to-powder route also lets it take in titanium scrap; the US Government has transferred scrap to the company, including about 290 metric tonnes cited alongside a final US$4.6M DoW funding payment.
Customer types and end-markets
Target sectors disclosed: defence (US Army GVSC, DoD programmes), aerospace, automotive (Ford contract cited in Q3 FY26 materials), consumer electronics (spherical AM powders under qualification), and industrial uses such as pump and valve parts [Q3 FY26].
Independent characterisation
IperionX is effectively a government-anchored industrial scale-up story. In FY2026 it carried a net loss of US$66.8M with no material revenue. Its main assets are (i) a process-technology portfolio now running continuously at small commercial scale, (ii) a de-risked but unfunded US critical-minerals deposit, and (iii) a strong policy tailwind from US efforts to re-shore titanium and rare-earth supply chains. The investment case rests on converting qualification work into recurring component revenue before the funding window closes. That conversion has not yet been demonstrated at scale.
Strategy
Stated strategic themes (2026 shareholder letter, Q3/Q4 FY26 reports, paraphrased):
-
Re-shore and build the world's lowest-cost titanium supply chain in the US using patented technologies.
-
2026 operating priorities: increase titanium throughput, broaden product mix, improve production consistency, and commission more downstream capacity [Q3 FY26].
-
Capacity roadmap: ~200 tpa powder run-rate by end-CY2026, ~1,400 tpa in 2027 (IBAS-funded), and more than 10,000 tpa of components by 2030 [Quartr FY26 summary; HY26].
-
GenX™: continuous HAMR for capital-efficient scaling through 2030.
-
Upstream integration: Titan DFS completed (June 2026); Atlas acquired (July 2026); an integrated Atlas–Titan economic assessment is targeted by end-2026 to quantify capital and schedule benefits [Q4 FY26].
-
Customer conversion: move qualification programmes (defence, aerospace, automotive, consumer electronics, industrial) into defined purchase orders, with revenue starting in 2H CY2026 [Q3 FY26].
Medium-term financial targets: no formal revenue or EBITDA guidance has been published. ESG positioning is low-energy, low-carbon titanium production (see §20).
Products & Services
Titanium metal and products
| Offering | Description / capability | Target customer | Status / year | Pricing |
|---|---|---|---|---|
| HAMR™ titanium powder | Hydrogen Assisted Metallothermic Reduction de-oxygenates titanium scrap or mineral feed into titanium/alloy powder; company claims cost 40–70% below Kroll by skipping sponge and melt steps | Powder buyers, own downstream use | Commercial-scale systems commissioned and in ramp-up (2026); run-rate target ~200 tpa by end-CY2026 | — |
| GenX™ continuous HAMR | Next-generation continuous HAMR platform aimed at higher productivity and capital efficiency | Internal (capacity scaling) | Unveiled Feb 2026; commercial-scale validation targeted in 2026 | — |
| Grade 5 (Ti-6Al-4V) alloy powder | Powder meeting or exceeding Grade 5 quality parameters | Aerospace, defence, industrial | Production FY2026 [Q4 FY26] | — |
| Spherical AM powders | Titanium powders for additive manufacturing | Consumer electronics, AM users | Qualification in progress [Q3 FY26] | — |
| HSPT™ near-net-shape parts | Hydrogen Sintering and Phase Transformation; validated at finished-product level [Q4 FY26] | Defence, aerospace, automotive | Prototype/qualification | — |
| THRM™ processing | Additional proprietary process validated with HSPT at finished-product level [Q4 FY26] | As above | Prototype/qualification | — |
| Titanium fasteners | Independent testing (US Army DEVCOM GVSC; Westmoreland Mechanical Testing & Research) showed torque yield above SAE Grade 8 steel and tensile values above common aerospace titanium-fastener standards | US Army (JLTV), defence, aerospace | Prototype orders 2025–26 | — |
| Powder-metallurgy pressed components | Six-axis PM press triples PM capacity and widens the range and complexity of parts | Industrial, defence | Commissioned May 2026 | — |
| Heavy ground-combat-system components | Prototype order for a US Army heavy ground combat system (TipRanks headline) | US Army | Prototype | — |
Critical minerals (future products, Titan/Atlas)
| Product | Phase 2 annual output (DFS) | Use |
|---|---|---|
| Ilmenite | 118,658 tpa | Titanium feedstock (HAMR) and pigment markets |
| Rutile | 24,656 tpa | High-grade titanium feedstock |
| Zircon | Disclosed in DFS | Ceramics, refractories |
| Heavy Rare Earth Concentrate (HREC) | Disclosed in DFS | Magnet supply chain |
Financial Narrative
Income statement
Sources: FY2026, FY2025 and FY2024 net loss from 20-F FY26 Note 18 (accumulated losses table: US$66,767,762; US$35,348,675; US$21,843,646). EPS and finance income FY2024–25 from the FY2025 Directors' Report (6-K).
Gross profit, operating income, EBITDA, pre-tax income and margins are not meaningful for a pre-revenue company, so margin rows are omitted. Marketscreener records reported EBITDA of about -21.6 (FY2024) and -36.3 (FY2025), USD M; these are aggregator figures. Revenue CAGR is not computable.
Half-year detail (H1 FY26 vs H1 FY25, USD M, per HY26 / Kalkine):
Data conflict: Kalkine reports H1 FY25 operating outflow as 11.48 and H1 FY25 financing as 6.21. The HY26 cash-flow statement (SEC 6-K) shows 11,748,806 and 68,206,221. The primary filing is preferred here.
Balance sheet
Interim points: at 31 Dec 2025, cash was US$65.8M, net assets US$108.2M and total assets about US$129.2M [HY26; VCP Scanner]. At 31 Mar 2026, cash was US$48.2M [Q3 FY26]. Pro-forma cash after the July 2026 raise and grant reimbursements was about US$84M (Panabee summary of Q4 FY26).
Total debt, net debt and working capital: the company is funded by equity and government grants [20-F FY25] and has no disclosed borrowings. Right-of-use assets at 30 June 2025 were US$3,752,600 (as corrected, 13 March 2026). Goodwill and intangibles: not disclosed separately in materials retrieved.
Cash flow
FY2025 operating cash flow is from FinancialFilings (citing the Annual Report filed 14 Oct 2025). The combined operating and investing outflow is from 20-F FY25. Implied FY2025 investing outflow is about -24.3. VCP Scanner reports FY2025 free cash flow of -54.7; this conflicts with the filing-derived -46.1 (operating plus investing, before netting any grant inflows) and is likely a definitional difference. The June 2026 quarter's operating cash burn was about US$12M (Panabee).
Equity raises:
Ratios
ROE, ROA and ROIC are all deeply negative. FY2026 ROE is about -75% on closing equity (66.8 / 88.3, simple calculation). Interest coverage, net debt/EBITDA, asset turnover and cash conversion cycle are not meaningful: there is no material revenue, EBITDA is negative, and there is no disclosed debt.
Commentary
The loss trajectory has steepened, from about US$22M in FY2024 to US$35M in FY2025 to US$67M in FY2026. The drivers are a step-up in R&D, ramp-up and commissioning costs in Virginia, exploration and DFS work at Titan, and much higher corporate and administrative expense. That expense rose almost fivefold in H1 FY26, reflecting a larger US team, dual-listing compliance and the costs of defending against the short-seller campaign.
The company has repeatedly ended years with cash below its annual burn and refilled the balance sheet through equity raises: A$70M in 2025 and US$50M in July 2026. FY2026 closing cash of US$35.2M fell within the company's guided range of US$36–40M only at the lower edge; strictly, it was slightly below. Government funding offsets part of the capital expenditure.
The key inflection to watch is whether product revenue appears in FY2027, as consensus models assume (see §21–22).
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Revenue
| Segment / activity (analyst grouping) | Contents | Products | Revenue FY2024 | Revenue FY2025 |
|---|---|---|---|---|
Titanium metal & products | Virginia campus (HAMR, HSPT, THRM, PM press, AM powders); Utah facility | Ti powder, near-net-shape parts, fasteners | Nil disclosed | Nil disclosed |
Critical minerals | Titan Project and Atlas property (Tennessee) | Ilmenite, rutile, zircon, HREC (future) | Nil | Nil |
Segment revenue (USD Mn)
| Segment revenue (USD Mn) | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Titanium metal & products | 0 | 0 | — |
Critical minerals | 0 | 0 | 0 |
Key Financials and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue (USD Mn) | 0 | 0 | 0 | 0 | — |
Net loss after tax (USD Mn, negative) | -21.5 | -17.4 | -21.8 | -35.3 | -66.8 |
Finance income (USD Mn) | — | — | 0.5 | 3.6 | — |
Basic & diluted EPS (USD per ordinary share) | — | — | -0.10 | -0.12 | — |
Dividends per share (USD) | 0 | 0 | 0 | 0 | 0 |
Cash Flow
| Metric (USD Mn) | H1 FY25 | H1 FY26 |
|---|---|---|
Loss for the period | -16.24 | -34.76 |
Corporate & administrative expense | 3.28 | 16.21 |
Business development expense | 2.15 | 1.65 |
Share-based payments expense | 6.91 | 4.67 |
Net cash used in operating activities | -11.75 | -16.70 |
Net cash used in investing activities | -10.97 | -16.38 |
Net cash from financing activities | 68.21 | 43.92 |
Balance Sheet
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Cash & equivalents (USD Mn) | 33.2 | 54.8 | 35.2 |
Total assets (USD Mn) | — | 105.0 | — |
Net assets / equity (USD Mn) | — | 92.4 | 88.3 |
Accumulated losses (USD Mn, negative) | -73.9 | -109.2 | -176.0 |
Cash Flow (Annual)
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Operating cash flow (USD Mn) | — | -21.8 | — |
Operating + investing outflow (USD Mn, negative) | -25.1 | -46.1 | — |
Dividends paid (USD Mn) | 0 | 0 | 0 |
Buybacks (USD Mn) | 0 | 0 | 0 |
Raise Details
| Raise | Date | Gross proceeds |
|---|---|---|
Placement, 14.0M shares at A$5.00 (tranche 1), total A$70M | Jul–Oct 2025 | ~US$46M |
Underwritten Nasdaq ADS offering, 2,275,000 ADS at US$21.98 | 7–9 Jul 2026 | ~US$50M |
Geographic revenue (USD Mn)
| Geographic revenue (USD Mn) | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
United States | 0 | 0 | — |
Australia | 0 | 0 | 0 |
Rest of world | 0 | 0 | 0 |
Data Point Details
| Data point | Value | Source / date |
|---|---|---|
ASX close | A$4.15 | 7 Jul 2026 (prospectus) |
Nasdaq ADS close | US$28.36 | 6 Jul 2026 |
Offering price | US$21.98/ADS | 7 Jul 2026 |
Nasdaq ADS | US$24.10; market cap ~US$895M | 14 Aug 2026 |
Nasdaq 52-week range | US$20.09 – US$61.45 | As of 14 Aug 2026 |
ASX 2026 range (to ~late Jul) | Open A$5.51; high A$8.44; low A$3.05; down ~41% YTD | InvestSMART |
Nasdaq total return CAGR | 1-year ~56%; 3-year ~84% (as of 4 Mar 2026) | iOCharts |
Analyst Ratings & Targets
| Broker | Rating | Target (USD) | Note |
|---|---|---|---|
Roth Capital | Buy (implied) | 53 (cut from 75) | 2,026 |
Texas Capital (M. Key) | Buy | 55 | Initiation 2026 |
BTIG | Buy | 55 (from 40) | — |
William Blair | Outperform | — | Initiation |
Consensus (StockAnalysis) | — | 49.40 | Recent |
Income Statement
| Consensus forecast (USD Mn) | FY2026 | FY2027 | FY2028 |
|---|---|---|---|
Net sales consensus (USD Mn) | 12.6 | 81.7 | 252 |
EBITDA consensus (USD Mn) | -19.7 | 28.2 | 139 |
Net income consensus (USD Mn) | -19.9 | 12.3 | 136 |
Analyst Conclusions
Guidance: ~200 tpa powder run-rate by end-CY2026; ~1,400 tpa in 2027; more than 10,000 tpa of components by 2030; customer revenue to start in 2H CY2026; integrated Atlas–Titan study by end-2026.
Bull case
-
The HAMR ramp to 200 tpa, with Grade 5 output, proves the cost advantage. The IBAS-funded jump to 1,400 tpa then creates real operating leverage.
-
Defence fastener qualification (JLTV, ground combat systems) converts into programme volumes under the SBIR III vehicle, which is worth up to US$99M.
-
The Titan DFS (NPV8 US$813M) alone approaches the company's recent market cap, so the metals business is effectively a free option if Titan is financed.
Bear case
-
FY2026 loss of US$66.8M against US$35.2M cash, with repeated discounted raises, points to further dilution.
-
Revenue timelines have slipped and consensus has been badly wrong, as the FY2026 loss forecast of -19.9 against actual -66.8 shows.
-
Control lapses (March 2026 correction), active shorts and potential litigation keep the stock at a credibility discount.
Catalysts and monitorables (next 12 months): the September 2026 quarterly (29 Oct 2026), especially throughput, first revenue and cash; whether 200 tpa is reached by December 2026; GenX™ validation data; the Atlas–Titan study; Titan project-finance progress (government lenders, offtake); GVSC and Ford order conversion; short-seller follow-ups; the status of securities claims.
Analyst verdict. IperionX has advanced further than most of its powder-metallurgy peers. It is running a patented primary-titanium process 24/7 at commercial scale in the United States, its output meets Grade 5 specifications, and its components have passed independent defence testing. Washington has visibly committed to the company through IBAS, DPA Title III and an SBIR Phase III vehicle, and through scrap transfers. The Titan DFS adds a credible, permitted upstream asset with headline economics that look attractive relative to the equity value.
Yet the financial record remains that of a development company. FY2026 losses nearly doubled to US$66.8M, cash ended the year at US$35.2M, and accumulated losses reached US$176M. The company has had to raise equity twice in about twelve months, most recently at a steep discount. The March 2026 correction was immaterial in accounting terms, but it gave short sellers a narrative and cost management credibility at a sensitive moment. Revenue guidance has repeatedly moved to the right, and the published consensus is clearly stale.
The investment question is therefore narrow and binary over the next four to six quarters. Can Virginia demonstrate repeatable throughput near 200 tpa, with recognisable unit costs and the first recurring purchase orders, before another raise is needed? If yes, the 1,400 tpa expansion is already government-funded and the equity story could re-rate. If no, dilution compounds and the Titan option may have to be monetised on weaker terms.
On balance, we view IperionX as a high-risk, policy-levered special situation. Verification of the 29 October 2026 quarterly report should be treated as the next decision point.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Notes |
|---|---|---|
Anastasios (Taso) Arima | Founder, CEO & Managing Director | Bought shares on market in Feb, Mar and Apr 2026 |
Toby Symonds | President | Named in company contacts (2026 releases) |
Dominic Allen | Chief Commercial Officer | Named in company contacts |
Marcela Castro | Chief Financial Officer (principal financial officer) | Signed SOX s.906 certification, 29 Sep 2026 |
Board of Directors
| Name | Role | Recent dealings |
|---|---|---|
Todd Hannigan | Chair (Executive Chair per company disclosures; verify title in 20-F FY26) | Bought 480,000 shares (29 Apr 2026, ~A$2.08M); bought 225,225 (27 Mar 2026); exercised/bought 159,333 (Feb 2026); issued securities Apr 2026 |
Lorraine Martin | Non-executive director | Bought 47,550 shares (28 Apr 2026) |
Vaughn Taylor | Non-executive director | Sold 150,000 shares (4 Feb 2026, ~A$1.03M) |
Melissa Waller | Non-executive director | Sold 150,000 shares (15 Sep 2025, ~A$1.0M) |
R. (Tony) Tripeny | Non-executive director | Bought 41,870 shares (23 Dec 2025) |
Competitive Landscape
Key Competitors
| Competitor | Segment overlap | Positioning vs IperionX |
|---|---|---|
VSMPO-AVISMA (Russia) | Titanium sponge, mill products | World's largest integrated producer; geopolitically constrained in Western markets |
Toho Titanium (Japan) | Kroll sponge, powders | Established Kroll incumbent; supplies Western aerospace |
OSAKA Titanium Technologies (Japan) | Kroll sponge, powders | Established incumbent |
ATI Inc. (US) | Titanium mill products, specialty alloys | Scale incumbent and potential customer/competitor |
Howmet Aerospace (US) | Titanium components, fasteners | Major aerospace fastener incumbent |
Precision Castparts / TIMET (Berkshire Hathaway) | Integrated titanium, fasteners | Major US incumbent |
Carpenter Technology (US) | Specialty alloys, AM powders | Powder and AM competitor |
6K Additive (US) | Recycled AM powders | Powder competitor |
Amaero (ASX: 3DA) | US atomised titanium AM powder | Direct powder peer |
Titomic (ASX: TTT) | Cold-spray titanium | Adjacent ASX peer |
Iluka Resources / Chemours (mineral sands) | Ilmenite, rutile, zircon | Upstream incumbents relative to Titan |
MP Materials / Energy Fuels | Rare earths | HREC market context |
Peer Comparison FY2026
| Metric | IperionX (FY2026) | ATI (FY2024) | Howmet (FY2024) | Carpenter (FY2025, Jun) |
|---|---|---|---|---|
Revenue (USD Mn) | — | ~4,360 | ~7,430 | ~2,880 |
Net result (USD Mn) | -66.8 | — | — | — |
R&D intensity | n/m | — | — | — |
Recent Developments
--



